PMID- 32819925
OWN - NLM
STAT- MEDLINE
DCOM- 20210514
LR  - 20210514
IS  - 2044-6055 (Electronic)
IS  - 2044-6055 (Linking)
VI  - 10
IP  - 8
DP  - 2020 Aug 20
TI  - Patients' experiences regarding self-monitoring of the disease course: an 
      observational pilot study in patients with inflammatory rheumatic diseases at a 
      rheumatology outpatient clinic in The Netherlands.
PG  - e033321
LID - 10.1136/bmjopen-2019-033321 [doi]
LID - e033321
AB  - OBJECTIVES: Self-monitoring the disease course is a relatively new concept in the 
      management of patients with inflammatory rheumatic diseases (IRDs). The aims of 
      this pilot study were to obtain patients' experiences with online 
      self-monitoring, to assess information about the agreement between the disease 
      course assessed with patient-reported outcome measures (PROMs) and an objectively 
      measured Disease Activity Score 28 (DAS28) by the rheumatologist, and to assess 
      adherence to predetermined PROM frequency intervals. DESIGN: Observational study 
      using qualitative and quantitative methods. SETTING: The rheumatology outpatient 
      clinic of a teaching hospital in The Netherlands (secondary care). PARTICIPANTS: 
      47 patients with an IRD who regularly attended the outpatient clinic. METHODS: 
      Patients completed PROMs by using an online self-monitoring program. Their 
      experiences regarding self-monitoring were qualitatively assessed through a focus 
      group discussion and telephone interviews using a thematic analysis approach. 
      Adherence to the predefined PROM frequency (completed PROM assessments within the 
      predetermined frequency) and the agreement between the DAS28 course and PROM 
      values (Rheumatoid Arthritis Disease Activity Index-5 and the Rheumatoid 
      Arthritis Impact of Disease (RAID)) were quantitatively assessed using 
      descriptives. RESULTS: Forty-seven patients participated, most of them diagnosed 
      with rheumatoid arthritis (n=38, 80.9%). Three themes were identified: knowledge 
      about and insight into the disease (activity), patient-professional interaction 
      and functionality of the program. Mean adherence to the predetermined PROM 
      frequency was 68.1%. The RAID showed the best agreement with the DAS28 course. 
      Mean participation time was 350 days. CONCLUSION: Patients were predominantly 
      positive about online self-monitoring. They indicated that they gained more 
      knowledge about their disease, felt less dependent on the healthcare professional 
      and valued the insight into their long-term disease course. Barriers were mostly 
      related to technical factors. Patients were able to and willing to self-monitor 
      their disease, which could contribute to a more efficient allocation of 
      outpatient consultations in the future.
CI  - (c) Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No 
      commercial re-use. See rights and permissions. Published by BMJ.
FAU - Renskers, Lisanne
AU  - Renskers L
AUID- ORCID: 0000-0003-1413-1629
AD  - IQ Healthcare, Radboudumc, Nijmegen, Gelderland, The Netherlands 
      Lisanne.Renskers@radboudumc.nl.
FAU - Rongen-van Dartel, Sanne Aa
AU  - Rongen-van Dartel SA
AD  - IQ Healthcare, Radboudumc, Nijmegen, Gelderland, The Netherlands.
AD  - Rheumatology, Bernhoven Hospital Location Uden, Uden, Noord-Brabant, The 
      Netherlands.
FAU - Huis, Anita Mp
AU  - Huis AM
AD  - IQ Healthcare, Radboudumc, Nijmegen, Gelderland, The Netherlands.
FAU - van Riel, Piet Lcm
AU  - van Riel PL
AD  - IQ Healthcare, Radboudumc, Nijmegen, Gelderland, The Netherlands.
AD  - Rheumatology, Bernhoven Hospital Location Uden, Uden, Noord-Brabant, The 
      Netherlands.
LA  - eng
PT  - Journal Article
PT  - Observational Study
PT  - Research Support, Non-U.S. Gov't
DEP - 20200820
PL  - England
TA  - BMJ Open
JT  - BMJ open
JID - 101552874
SB  - IM
MH  - Ambulatory Care Facilities
MH  - *Arthritis, Rheumatoid/therapy
MH  - Humans
MH  - Netherlands
MH  - Pilot Projects
MH  - *Rheumatology
PMC - PMC7440711
OTO - NOTNLM
OT  - education & training (see medical education & training)
OT  - qualitative research
OT  - rheumatology
COIS- Competing interests: This study was partly funded by Pfizer (pharmaceutical 
      company). Pfizer was able to access data available from iMonitor. Pfizer was not 
      involved in any medical policy related to the study participants.
EDAT- 2020/08/21 06:00
MHDA- 2021/05/15 06:00
PMCR- 2020/08/20
CRDT- 2020/08/22 06:00
PHST- 2020/08/22 06:00 [entrez]
PHST- 2020/08/21 06:00 [pubmed]
PHST- 2021/05/15 06:00 [medline]
PHST- 2020/08/20 00:00 [pmc-release]
AID - bmjopen-2019-033321 [pii]
AID - 10.1136/bmjopen-2019-033321 [doi]
PST - epublish
SO  - BMJ Open. 2020 Aug 20;10(8):e033321. doi: 10.1136/bmjopen-2019-033321.